About me
Sarah Spencer is a Corporate Communications professional with over 25 years of experience in the pharmaceutical, life sciences, and biotechnology industries. She currently serves as Vice President of Corporate Communications & Investor Relations at Vor Bio. Sarah's expertise includes media and investor relations, Board & C-suite communications, corporate branding, internal communications, crisis communications, and more. Previously, she founded SJS Communications, a consulting agency specializing in biotech communications. Sarah also held senior roles at Audentes Therapeutics (acquired by Astellas Pharma) and GSK, where she led various global and U.S. communications initiatives. She has a strong track record in brand and reputation management, internal, external, financial and investor communications, and patient advocacy, demonstrating her versatile expertise in managing complex communication strategies across different audiences. Outside of her professional endeavors, Sarah is passionate about mentorship and actively supports initiatives aimed at empowering the next generation of communications professionals. Sarah holds a Bachelor's degree in Communication and Psychology from SUNY Buffalo.